Back
Sarepta Therapeutics Vs. AbbVie Industry Stock Comparison
Buy
52
SRPT
Sarepta Therapeutics
Last Price:
126.93
Seasonality Move:
16.32%
Sell
42
ABBV
AbbVie
Last Price:
161.91
Seasonality Move:
1.92%
Buy
52
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $128.80. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $161.52. The Score for ABBV is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $128.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 61.99 | Buy |
| Chaikin Money Flow: | -291612 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.47 - 128.97) | Buy |
| Bollinger Bands (100): | (102.98 - 131.42) | Buy |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.05 | Sell |
| Relative Strength Index (14 RSI): | 35.98 | Sell |
| Chaikin Money Flow: | 6090539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (163.13 - 176.77) | Sell |
| Bollinger Bands (100): | (158.08 - 177.58) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.91 | Buy |
| 20-day SMA: | 123.06 | Buy |
| 50-day SMA: | 126.08 | Buy |
| 200-day SMA: | 111.7 | Buy |
| 8-day EMA: | 124.31 | Buy |
| 20-day EMA: | 123.46 | Buy |
| 50-day EMA: | 122.91 | Buy |
| 200-day EMA: | 116.14 | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 165.59 | Sell |
| 20-day SMA: | 167.39 | Sell |
| 50-day SMA: | 174.19 | Sell |
| 200-day SMA: | 156.95 | Buy |
| 8-day EMA: | 164.63 | Sell |
| 20-day EMA: | 167.6 | Sell |
| 50-day EMA: | 170.01 | Sell |
| 200-day EMA: | 160.73 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.72 per share, an increase next quarter of $3.22 per share, an increase this year of $5.19 per share, and an increase next year of $7.23 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.20 per share, an increase this year of $0.09 per share, and an increase next year of $0.84 per share.
Sarepta Therapeutics Technical Analysis
| Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||